UC Berkeley vs. Broad Institute CRISPR War: Who Owns Your IP?
A decade-long patent war between UC Berkeley and the Broad Institute over CRISPR gene editing offers four hard lessons for researchers entering industry partnerships.
How AI is Revolutionizing a New Era of Scientific Discovery
Imagine a research assistant that never gets tired, can read millions of scientific papers in minutes, and spots patterns that would take human scientists years to find. That’s what artificial intelligence is becoming for scientists around the world, and it’s transforming how we make breakthrough discoveries.
Machine Learning Applications in Pharmacokinetic Modeling
Machine learning revolutionizes pharmacokinetic modeling by enabling accurate drug behavior prediction, reducing experimental requirements, and accelerating drug development through advanced computational approaches.
How AI is Revolutionizing Drug Target Identification
Artificial intelligence accelerates drug target discovery from decades to months, with AI-identified compounds entering clinical trials and showing promising validation rates in experimental studies.
AI Patents Block Life-Saving Drug Discovery
AI patents for untested molecules at drug companies may be blocking medical breakthroughs by preventing competitors from developing potentially life-saving treatments.